Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Skeletal Myoblast Transplant for Treating Ischemic Heart Failure

NCT00102128 is registered in ClinicalTrials.gov with Genzyme, a Sanofi Company as lead sponsor.

NCT NCT00102128
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00102128 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Skeletal Myoblast Transplant for Treating Ischemic Heart Failure
Lead sponsor
Genzyme, a Sanofi Company
Phase
Phase 2
Overall status
Terminated
Start date
November 30, 2002
Completion date
April 30, 2007
Enrollment
Not reported
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic cardiomyopathy, ischemic heart disease, ischemic heart failure